Id4 promotes cell proliferation in hepatocellular carcinoma.

CONCLUSION: Id4 may be developed as a potent therapeutic agent for the treatment of HCC, but more details about the underlying mechanisms of action are needed. PMID: 28143562 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28143562?dopt=Abstract

Source: Chinese Journal of Cancer - February 3, 2017 Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research